Repeated Humanin Treatment Attenuates Oxidative Stress, Inflammation, and Apoptosis in Diabetic Cardiac Tissue.
Repeated Humanin treatment may help reduce oxidative stress and inflammation in the hearts of diabetic mice, but further research is needed to understand its relevance in humans.
Where it sits
this study against the rest of the humanin corpusSummary and findings
This study investigated the effects of repeated Humanin (HN) treatment on oxidative stress, inflammation, and apoptosis in a streptozotocin-induced diabetic mouse model. Mice received HN at a dose of 4 mg/kg daily for 15 days. The study found that HN treatment attenuated diabetes-induced alterations in cardiac tissue.
Abstract
Diabetes mellitus (DM) markedly increases the risk of cardiovascular complications through mechanisms involving hyperglycemia-induced oxidative stress, inflammation, and apoptosis. Humanin (HN), a mitochondria-derived peptide with established cytoprotective properties, has been reported to exert antioxidant and anti-apoptotic effects in several experimental models. However, its role in diabetic cardiac injury remains insufficiently understood. The present study investigated the protective effects of repeated HN treatment against diabetes-induced cardiac injury in a streptozotocin (STZ)-induced mouse model. Mice were divided into four groups: control, HN-treated, STZ-induced diabetic, and STZ + HN-treated groups (<i>n</i> = 10/group). HN (4 mg/kg) was administered daily for 15 consecutive days. Biochemical analyses were performed to evaluate oxidative stress, inflammatory cytokines, and apoptotic markers. STZ-induced diabetes significantly increased oxidative stress markers, pro-inflammatory cytokines, and apoptotic activity while reducing antioxidant defenses and anti-inflammatory cytokines compared with controls. Repeated HN treatment markedly attenuated these alterations and restored redox and inflammatory balance in diabetic cardiac tissue. These findings demonstrate that repeated HN treatment attenuates oxidative stress, inflammation, and apoptosis in the hearts of diabetic mice. The results further suggest that HN may represent a promising therapeutic candidate for limiting diabetes-associated cardiac complications.
Background
The paper addresses the impact of Humanin on oxidative stress, inflammation, and apoptosis in diabetic cardiac tissue, which are critical factors in diabetic cardiomyopathy. Prior research has indicated that oxidative stress and inflammation contribute to cardiac dysfunction in diabetes, but the role of Humanin in mitigating these effects was not well established. This study aims to fill that gap and explore the potential of Humanin as a therapeutic agent.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Key findings
- Not reported in abstract.
- Not reported in abstract.
- Not reported in abstract.
Limitations
- Not reported in abstract.